Denali Therapeutics Inc. (DNLI) vs Ultragenyx Pharmaceutical Inc. (RARE)
Detailed comparison between Denali Therapeutics Inc., Ultragenyx Pharmaceutical Inc..Total Return (%)
Denali Therapeutics Inc. (DNLI)Ultragenyx Pharmaceutical Inc. (RARE)
Which stock do you think will perform better?
Denali Therapeutics Inc.
DNLI
Ultragenyx Pharmaceutical Inc.
RARE
| Metric | Denali Therapeutics Inc. (DNLI) | Ultragenyx Pharmaceutical Inc. (RARE) |
|---|---|---|
| Current Price | $14.00 | $26.31 |
| Change | -0.53 (-3.65%) | -1.10 (-4.01%) |
| Market Cap | $2.03B | $2.49B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -5.09 | -5.15 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $33.33 | $60.37 |
| 52-Week Low | $10.57 | $26.00 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-2.67 | $-5.83 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| DNLI | 0.79% | -39.24% | -34.76% | -50.44% | -34.73% | -34.73% |
| RARE | -29.16% | -36.26% | -38.17% | -70.07% | -80.38% | -80.38% |